$16.84
0.17 (+1.02%)
BioMarin Pharmaceutical, Inc. (BMRN)
CAPS Rating:
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.